HIF Away: Roxadustat Has Arrived!

August 2, 2016 // 0 Comments

Anemia management in patients with end-stage renal disease (ESRD) has always been a complicated process.  Prior to the introduction of recombinant human erythropoietin, the vast majority of patients receiving dialysis were transfusion dependent.  [read more...]

#SCM16: Vadadustat and Anemia

April 29, 2016 // 0 Comments

Dr. Volker Haase (VH), from Vanderbilt University in Nashville, Tennessee, discusses his abstract for the National Kidney Foundation’s 2016 Spring Clinical Meetings (SCM16), Vadadustat Maintains Stable Hemoglobin Levels in Dialysis Patients [read more...]

Before and After TREAT

September 8, 2014 // 0 Comments

In a recent article published in AJKD, Thamer at al did a retrospective observational investigation of the ESA prescribing patters before and after publication of the TREAT trial, and even referred to TREAT as a “watershed” study. As [read more...]

SCM14: Let’s Bind With Velphoro

April 24, 2014 // 1 Comment

Dr. Stuart Sprague (SS) from the North Shore University Health System and University of Chicago Pritzker School of Medicine discusses his abstract for the National Kidney Foundation’s 2014 Spring Clinical Meetings (SCM14), Concomitant Intravenous [read more...]